EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review)

Huiyuan Ma, Longhui Li, Conghan Jiao, Yanyan Cheng, Jiayu He, Chen Jiang, Qian Tong, Dan Yi, Ying Zhang

Oncology Reports · 2026

DOI: 10.3892/or.2026.9049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, 2026. Verfasst von Huiyuan Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Protein Kinase Inhibitors, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsProtein Kinase InhibitorsImmunotherapyImmune Checkpoint InhibitorsHumansErbB ReceptorsTumor MicroenvironmentDrug Resistance, NeoplasmMutationB7-H1 Antigen

Stichwörter der Autor:innen

epidermal growth factor receptor‑tyrosine kinase inhibitorsimmune checkpoint inhibitorsnon‑small cell lung cancerprogrammed death ligand 1tumor microenvironment

Substanzen

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, humanImmune Checkpoint InhibitorsB7-H1 Antigen

Autor:innen und Institutionen

  • Department of Hematology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China.
  • National Clinical Research Center for Chinese Medicine, Tianjin 300193, P.R. China.

Zitieren

APA

Ma, H., Li, L., Jiao, C., Cheng, Y., He, J., Jiang, C., Tong, Q., Yi, D., & Zhang, Y. (2026). Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review). Oncology Reports. https://doi.org/10.3892/or.2026.9049

Vancouver

Ma H, Li L, Jiao C, Cheng Y, He J, Jiang C, et al. Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review). Oncology Reports. 2026. doi:10.3892/or.2026.9049

BibTeX
@article{Ma2026,
  author = {Ma, Huiyuan and Li, Longhui and Jiao, Conghan and Cheng, Yanyan and He, Jiayu and Jiang, Chen and Tong, Qian and Yi, Dan and Zhang, Ying},
  title = {Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review)},
  journal = {Oncology Reports},
  year = {2026},
  doi = {10.3892/or.2026.9049}
}
Kostenlos starten →